Corrigendum to “Delivery of coenzyme Q10 loaded micelle targets mitochondrial ROS and enhances efficiency of mesenchymal stem cell therapy in intervertebral disc degeneration” [Bioact. Mater. 23 (2023) 247–260]

Junyuan Sun, Fei Yang, Lianlei Wang, Haichao Yu, Zhijie Yang, Jingjing Wei, Krasimir Vasilev, Xuesong Zhang, Xinyu Liu, Yunpeng Zhao

Research output: Contribution to journalComment/debate

2 Citations (Scopus)

Abstract

This corrects the article “Delivery of coenzyme Q10 loaded micelle targets mitochondrial ROS and enhances efficiency of mesenchymal stem cell therapy in intervertebral disc degeneration” in volume 23 on page 247. 

The authors regret that the printed version of the above article contains some errors which are not identified during the proofing stage. The authors regret: 

1. Due to a writing error, “The IHC images also suggested that the BMSCs + LM@Co-Q10 group suppressed the Col2 expression and enhanced the MMP13 and P65 expression …”, Page 258, needs to be corrected to “The IHC images also suggested that the BMSCs + LM@Co-Q10 group enhanced the Col2 expression and suppressed the MMP13 and P65 expression …”. The authors apologize for the error and state that the correction do not change the scientific conclusions of the article in any way.

2. The wrong IVIS and fluorescent images were selected during the assembly of Figs. 3A and 8A, although they did not affect the conclusion of this work. The images have been replaced with the correct images as follows. [Formula presented][Formula presented] The authors would like to apologize for any inconvenience caused.

Original languageEnglish
Pages (from-to)171-173
Number of pages3
JournalBioactive Materials
Volume24
Early online date20 Dec 2022
DOIs
Publication statusPublished - Jun 2023

Keywords

  • Intervertebral disc degeneration
  • Coenzyme Q10
  • Mesenchymal stem cell
  • Reactive oxygen species
  • Micelle

Fingerprint

Dive into the research topics of 'Corrigendum to “Delivery of coenzyme Q10 loaded micelle targets mitochondrial ROS and enhances efficiency of mesenchymal stem cell therapy in intervertebral disc degeneration” [Bioact. Mater. 23 (2023) 247–260]'. Together they form a unique fingerprint.

Cite this